🔗 Share this article

An underground market for unlicensed weight-loss drugs is propelled by social media fitness personalities and sellers on communication apps, according to recent findings.

Investigational Treatment Gaining Traction Online

The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its alleged fat-burning properties. Viewers are urged to message these profiles privately for source information, while also obtaining promotional offers.

Active Commerce on Social Networks

Additionally, a robust market exists on Telegram, where groups with thousands of members share “before and after” images, injection guides and assertions of rapid British shipping. Sellers market the substance there before directing buyers to other platforms for purchases.

Understanding The Experimental Drug

Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and glucagon. Early trials suggest it could help patients lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.

Healthcare Professionals Express Worries

Nevertheless, physicians and pharmacists have cautions that the distribution of what remains an unlicensed drug in the United Kingdom is worrisome and could result in users injecting products of unknown origin.

Several experts said the popularity for the experimental drug could be linked to the rising price of licensed slimming products such as Mounjaro.

Regulatory Status and Enforcement

Marketing retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.

Some influencers try to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still breach pharmaceutical, advertising, and customer regulations, risking penalties, legal action or imprisonment.

Platform Reaction and Content Elimination

According to the social media company, the service has removed problematic material and prohibited related keywords and search suggestions. The company stated it was dedicated to keeping the service secure and allocating resources in strengthening enforcement strategies.

Online Marketplace Activities

Investigations also found communities with up to 9,000 participants selling retatrutide using Telegram's built-in search feature, which functions like a online catalog. Entering “retatrutide” immediately displays groups with thousands of users, filled with images of weight loss, glowing reviews and detailed instructions for mixing or administering at residence.

After moments of joining one group, a vendor shared contact information, where the majority of purchases occur. The seller sent an instruction manual and guaranteed shipping within two days. When questioned whether the substance was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None inquired about body mass, health issues or previous experience.

Item Information and Costs

Inside these groups, posts display black plastic parcels with postal service stickers, stating to include new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at residence with sterile water, or ready-to-use pens typically sold at 160 pounds for 20 milligrams. When questioned how long a pen should be used, vendors give contradictory responses ranging from a several days to “depends on your body”.

Platform Moderation and Security Actions

A representative for Telegram said it actively moderated harmful material on its platform including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are injecting substances they cannot confirm. Even if the science behind retatrutide is valid, these online products may not contain what they claim,” said a pharmacy expert, the head of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor linked the surge in interest to recent cost increases for approved weight-loss medications such as Mounjaro. “With prices increasing, patients are turning to online platforms. But fake injections are extremely dangerous. You cannot know what’s contained or whether the conditions they were produced in was clean,” she said.

Her staff has previously seen individuals injured by self-injection from unconfirmed suppliers. “We recognize the frustration, but purchasing from messaging apps or communication platforms is gambling with your well-being,” stated the doctor. “These substances could be impure or improperly measured.”

Manufacturer Position

A spokesperson from the pharmaceutical company stated retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this point no one can sell [it] for personal consumption,” they said, adding that any product “misleadingly claiming itself as a Lilly experimental product not yet approved … may expose patients to potentially significant health risks”.